Medtronic just received FDA clearance and will soon make available its new MiniMed Connect device to keep an eye on insulin pumps and continuous glucose monitors. The device wirelessly interfaces with Medtronic’s MiniMed MiniMed 530G with Enlite or the MiniMed Paradigm Revel insulin pumps, which in turn have access to continuous glucose monitor sensor data. All this is passed via Bluetooth to the patient’s smartphone, where glucose charts and insulin injections are automatically tracked.

The readings can be shared with loved ones and caretakers, as well as with the patient’s physician for a more comprehensive assessment of the readings. The data can be viewed using a smartphone app or via a browser accessible website. Moreover, for increased safety, the app can automatically send out alerts to people on a list when sugar levels are too high or too low, or when an alarm on the pump is not addressed quickly by the user.

The MiniMed Connect device will be available for over-the-counter purchase for about $200. It is currently compatible with iPhones and iPod Touch devices, while an Android app is already in the works.

Source:Medtronic